131 related articles for article (PubMed ID: 30244488)
21. Ductus venosus pulsatility index measurement reduces the false-positive rate in first-trimester screening.
Timmerman E; Oude Rengerink K; Pajkrt E; Opmeer BC; van der Post JA; Bilardo CM
Ultrasound Obstet Gynecol; 2010 Dec; 36(6):661-7. PubMed ID: 20521242
[TBL] [Abstract][Full Text] [Related]
22. Fetal heart rate in chromosomally abnormal fetuses.
Liao AW; Snijders R; Geerts L; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2000 Dec; 16(7):610-3. PubMed ID: 11169365
[TBL] [Abstract][Full Text] [Related]
23. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.
Bromley B; Shipp TD; Lyons J; Navathe RS; Groszmann Y; Benacerraf BR
J Ultrasound Med; 2014 Oct; 33(10):1737-45. PubMed ID: 25253819
[TBL] [Abstract][Full Text] [Related]
24. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
25. Association of first trimester fetal heart rate and nuchal translucency with preterm birth.
Morales-Roselló J; Loscalzo G; Perez G; Payá AS; Jakaitė V; Perales-Marín A
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5572-5579. PubMed ID: 33618603
[TBL] [Abstract][Full Text] [Related]
26. [Analysis for the pregnancy outcome of cystic hygroma fetuses and correlation with increased nuchal translucency in first trimester].
Wang Q; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):665-670. PubMed ID: 30369121
[No Abstract] [Full Text] [Related]
27. Fetal heart rate and nuchal translucency in detecting chromosomal abnormalities other than Down syndrome.
Martinez JM; Echevarría M; Borrell A; Puerto B; Ojuel J; Fortuny A
Obstet Gynecol; 1998 Jul; 92(1):68-71. PubMed ID: 9649096
[TBL] [Abstract][Full Text] [Related]
28. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
29. Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing?
Lichtenbelt KD; Diemel BD; Koster MP; Manten GT; Siljee J; Schuring-Blom GH; Page-Christiaens GC
Prenat Diagn; 2015 Jul; 35(7):663-8. PubMed ID: 25754604
[TBL] [Abstract][Full Text] [Related]
30. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
van Vugt JM; van Zalen-Sprock RM; Kostense PJ
Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
[TBL] [Abstract][Full Text] [Related]
31. Pregestational diabetes and fetal heart rate in the first trimester of pregnancy.
Sirico A; Sarno L; Zullo F; Martinelli P; Maruotti GM
Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():30-32. PubMed ID: 30465928
[TBL] [Abstract][Full Text] [Related]
32. Screening for chromosomal anomalies in the first trimester: a report on the first year of prospective screening for chromosomal anomalies in the first trimester in the Czech Republic.
Dhaifalah I; Santavy J; Zapletalova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):275-8. PubMed ID: 17426792
[TBL] [Abstract][Full Text] [Related]
33. Long-term prognosis of pregnancies complicated by slow embryonic heart rates in the early first trimester.
Doubilet PM; Benson CB; Chow JS
J Ultrasound Med; 1999 Aug; 18(8):537-41. PubMed ID: 10447078
[TBL] [Abstract][Full Text] [Related]
34. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
35. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW
Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624
[TBL] [Abstract][Full Text] [Related]
36. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
37. Ductus venosus blood flow resistance and congenital heart defects in the second trimester.
Hung JH; Fu CY; Lu JH; Hung CY
J Clin Ultrasound; 2008 Feb; 36(2):72-8. PubMed ID: 17676619
[TBL] [Abstract][Full Text] [Related]
38. What are the most common first-trimester ultrasound findings in cases of Turner syndrome?
Wiechec M; Knafel A; Nocun A; Wiercinska E; Ludwin A; Ludwin I
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1632-1636. PubMed ID: 27491505
[TBL] [Abstract][Full Text] [Related]
39. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the fetal heart at 14 to 18 weeks' gestation in fetuses with a screening nuchal translucency greater than or equal to the 95th percentile.
Foy PM; Wheller JJ; Samuels P; Evans KD
J Ultrasound Med; 2013 Oct; 32(10):1713-9. PubMed ID: 24065251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
